Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
Precision pain management - Insights
Our liquid chromatography-tandem mass spectrometry, high-resolution accurate mass (LC-MS/MS HRAM) screens, and confirmatory testing for controlled substances are available based on the needs of your patients.
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
NGS Testing for Neuro-Oncology - Mayo Clinic Laboratories
Mayo Clinic is recognized worldwide for providing care for complex diseases including brain tumors. With rapid technological advancements and medical discoveries, the standard approach to genetic testing is evolving.
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Plasma-Cell Neoplasms - Mayo Clinic Laboratories
As a pioneer in the field, Mayo Clinic plays an integral role by developing new tests to help align patients with new therapies for plasma cell disorders.
Peripheral neuropathy - Insights
Learn about our peripheral neuropathy testing to identify autoimmune and genetic causes of the condition.
Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...
Cayuga Medical Center: Building a world-class lab that drives revenue - Insights
Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.
Cutting-edge lab work cracks a medical mystery: Kenneth Hobby - Insights
Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, where the mosquito-borne parasite is common. But anti-malaria drugs...
Diagnostic expertise leads to recovery from rare cancer: Alison O'Neill - Insights
After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the...
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Learn how our testing identifies genetic and autoimmune causes of epilepsy. Accurate diagnosis helps physicians identify potential treatment options.
On Demand Education organized by MLS credit categories.
Outreach & Business Solutions - Insights
Mayo Clinic Laboratories’ Outreach Program equips laboratory leaders with Mayo Clinic expertise and customized strategies to help grow laboratory revenues by increasing efficiencies and minimizing waste.
It's inspection time: 5 key areas to prepare in your off-site waived testing locations - Insights
With all the preparations required to ready a clinical laboratory for regulatory inspection, it can be easy to overlook offsite testing locations, especially those performing CLIA-waived tests. Hospital laboratories with a CLIA Certificate...
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
Saving and improving lives: The illuminating journey of a laboratory testing specimen - Insights
Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on...
Answers From the Lab - Insights
A Mayo Clinic podcast sharing knowledge and advances in testing, laboratory science, and the people who make it all happen behind the scenes. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
Skip to Content MayoACCESS MayoLINK...
Skip to Content MayoACCESS MayoLINK...
Skip to Content MayoACCESS MayoLINK...
Check out how key tactics for laboratory outreach can increase revenues, decrease cost, and improve patient care.
What's New in Health Care Reform: Jan. 2 - Insights
Top highlights include: "big pharma" returning to raising U.S. prices in January after pause; crowdfunding drives funds and attention toward questionable medical treatments; Americans rate health care providers high on honesty, ethics,...
Boone Health: Bringing advanced diagnostic care to underserved rural areas - Insights
Situated in a sprawling geographic region in mid-Missouri, Boone Health expanded its reach to improve access to high-quality holistic care throughout the area, improving the health of community members and increasing net revenue along the...
CPT codes and LOINC update: March 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of March.
Antimicrobial susceptibility testing determines whether these bacteria are susceptible or resistant to a particular antibiotic. Bacteria are added onto plates of solid agar, where each plate has a different and increasing concentration of...
Lung Transplant Recipient's First Breath Goes Viral #ThrowbackThursday - Insights
Jennifer Jones lay in a hospital bed about to take her first breath with new lungs. Cystic fibrosis had stolen Jennifer's breath, and so much more, over the years. A lung transplant gave her a chance to get some of it back.
1830s and 1840s: Mayo's First Mentor #ThrowbackThursday - Insights
When making an announcement or accepting a professional recognition, William J. Mayo, M.D., and Charles Mayo, M.D., often spoke in terms of “my brother and I” and “our father taught us.” These statements are some of the institution’s...
The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...
The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...
Improving diagnosis of rare congenital disorders - Insights
Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.
Check out how key tactics for laboratory outreach can increase revenues, decrease cost, and improve patient care.
New tests launched in January - Insights
In January 2022, Mayo Clinic Laboratories announced twenty five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Lymphomas Testing - Mayo Clinic Laboratories
To assist clinicians with lymphoma diagnosis, Mayo Clinic has a highly experienced, 9-member hematopathology section focusing on lymphoma diagnosis, which diagnoses more than 3,000 lymphoma cases per year.
Coagulation Disorders - Mayo Clinic Laboratories
Our special coagulation laboratory has been at the forefront of patient-centered and value-based diagnostic laboratory testing, research, and patient management for nearly 90 years.
Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich - Insights
After immigrating to the United State and becoming a U.S. citizen at the age of 18, Holocaust survivor Kurt Glover-Ettrich chose to give back to his new homeland by serving a 30-year career in the U.S. military. Today, as a Mayo Clinic...
Delta Health: Confronting a global pandemic in rural Colorado - Insights
Delta Health leveraged their relationship with Mayo Clinic Laboratories to support patient in rural Colorado during the COVID-19 pandemic. Delta Health and Mayo Clinic Laboratories have collaborated for over 17 years to perform complex and...
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting...
Atria Senior Living: COVID-19 testing protects the most vulnerable - Insights
When most of the world was still struggling to understand how COVID-19 would affect their lives, Atria Senior Living took steps to protect their vulnerable residents and staff.
Collaboration that changes lives: Elyn Simmons - Insights
Working together, Mayo Clinic laboratory medicine specialists and clinicians helped Elyn Simmons get her life back — and welcome two new lives to the world.
Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...
Back from the brink: Sheila Lewis - Insights
Mayo Clinic Laboratories’ comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from autoimmune encephalitis.
Embracing the transformative power of digital pathology - Insights
Mayo Clinic is harnessing the extraordinary potential of digital pathology through a robust initiative that’s using the technology to enhance patient care. Mayo’s Dermatology Department is an early adopter, and clinicians, students, and...